This sub-study of the SERVE-HF study found unchanged peripheral nervous sympathetic activity (MSNA) in heart failure patients on medical treatment or on ASV after 12 weeks. Reduced MSNA was associated with worse prognosis only in the ASV group
Bonsignore M.R., La Rovere M.T. (2023). Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe? [10.1183/13993003.02170-2022].
Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe?
Bonsignore M. R.
Primo
Writing – Original Draft Preparation
;
2023-01-01
Abstract
This sub-study of the SERVE-HF study found unchanged peripheral nervous sympathetic activity (MSNA) in heart failure patients on medical treatment or on ASV after 12 weeks. Reduced MSNA was associated with worse prognosis only in the ASV group
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
BonsignoreLaRovere-on-TamisierERJ2023.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
208.48 kB
Formato
Adobe PDF
|
208.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
